Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 2Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 217Breast 88Head & Neck 13Other solid neoplasm 8Tumor-Agnostic 5Other neoplasm 2NET 2Lymphoid 2Endocrine 2Thoracic 1Sarcoma 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Waldenstrom Macroglobulinemia 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Pancreatic Neoplasms 1Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Colonic Neoplasms 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

Cyclophosphamide 137Rituximab 112Etoposide 77Vincristine 74Doxorubicin 61Cytarabine 61Dexamethasone 58Prednisone 54fludarabine 52Methotrexate 46N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 42Lenalidomide 36Gemcitabine 35Radiotherapy 29Melphalan 27pegaspargase 22Prednisolone 22Ifosfamide 22Busulfan 20fludarabine phosphate 19Cisplatin 19Bendamustine Hydrochloride 19Asparaginase 18Peripheral Blood Stem Cell Transplantation 17Carmustine 16ibrutinib 15Mercaptopurine 15Filgrastim 15Decitabine 15Oxaliplatin 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Capecitabine × Lymphoid × Clear all
NCT04522284 2023-03-29

PRECISE CURATE.AI Pilot Clinical Trial

National University Hospital, Singapore

Phase 1/2 Unknown
20 enrolled
Lymphoid

Waldenstrom Macroglobulinemia, Neoplasms

NCT03775525 2022-12-23

GEN602

Genzada Pharmaceuticals USA, Inc.

Phase 1 Unknown
127 enrolled
BreastDermatologicGastrointestinalHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Basal Cell, Colonic Neoplasms, Lymphoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡